HOOKIPA Pharma Inc. is a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform.

$16.88  +0.18 (1.05%)
As of 05/13/2021 15:59:04 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/18/2019
Outstanding shares:  25,994,658
Average volume:  179,000
Market cap:   $395,378,748
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    43906K100
ISIN:        US43906K1007
Sedol:      BJ5K4M7
Valuation   (See tab for details)
PE ratio:   -9.48
PB ratio:   3.07
PS ratio:   20.19
Return on equity:   -28.23%
Net income %:   -225.09%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy